. Author manuscript; available in PMC: 2014 Jul 29.

Published in final edited form as: Hepatology. 2006 Nov;44(5):1110–1116. doi: 10.1002/hep.21388

Table 3. Serum HBV DNA Decrease in A5127 Study Subjects During Therapy With ADV or TDF.

	HBV DNA drop	w 12	w 24	w 36	w 48
ADV (n = 25)	<2	3	0	0	1
	2-4	17	15	11	8
	>4	3	5	7	8
	n/a	2	5	7	8
TDF (n = 27)	<2	1	1	1	1
	2-4	8	4	1	3
	>4	14	13	15	14
	n/a	4	9	10	9

w, Week; n/a: number of subjects for whom data was not available at that time.